What will be the public awareness level of the alcohol-cancer link by end of 2025?
Less than 50% • 25%
50% to 60% • 25%
61% to 70% • 25%
More than 70% • 25%
Public health surveys or studies conducted by reputable organizations
Surgeon General Urges Tobacco-Like Cancer Warnings on Alcohol; Stocks Fall in U.S. and Europe
Jan 3, 2025, 05:52 PM
The U.S. Surgeon General, Vivek Murthy, has called for cancer warning labels to be added to alcoholic beverages in the United States, similar to those on tobacco products. Murthy highlighted that alcohol consumption is the third leading preventable cause of cancer in the country, contributing to approximately 100,000 cancer cases and 20,000 deaths annually. Despite this, less than half of Americans are aware of the link between alcohol and cancer risk. The consumption of any type of alcohol increases the risk of at least seven types of cancer, including breast, colorectal, esophageal, liver, mouth, and throat cancers. The Surgeon General's proposal would require Congressional approval, as alcohol labels in the U.S. have not been updated in decades despite new scientific evidence. Following the announcement, stocks of major alcohol producers fell in both the U.S. and Europe, with Constellation Brands—the producer of Modelo and Corona—losing about $450 million in market capitalization. Other companies such as Anheuser-Busch InBev, Brown-Forman, Diageo, Heineken, and Boston Beer Company also saw their shares decline.
View original story
Decreases • 25%
Remains the same • 25%
Increases slightly • 25%
Increases significantly • 25%
Increased by 30% • 25%
Increased by more than 30% • 25%
Increased by 10% • 25%
Increased by 20% • 25%
No • 50%
Yes • 50%
Less than 40% support • 25%
40-59% support • 25%
60-79% support • 25%
80% or more support • 25%
Significant backlash against warnings • 25%
Increase in awareness but no significant change in consumption • 25%
Significant increase in awareness and reduction in consumption • 25%
No significant change in awareness or consumption • 25%
Criticize or oppose • 25%
No official response • 25%
Neutral stance • 25%
Support and endorse • 25%
0-25% • 25%
76-100% • 25%
51-75% • 25%
26-50% • 25%
Liver Cancer • 25%
Other • 25%
Esophageal Cancer • 25%
Breast Cancer • 25%
Decreased by over 10% • 25%
No significant change • 25%
Remained within 10% range • 25%
Increased by over 10% • 25%